Ipca Laboratories Ratlam
- All
- News
-
Ipca Labs Falls 15% As US Regulator Bans Drug Import
According to Ipca Laboratories, the FDA has refused admission to all drugs made at the company's Pithampur and Silvassa facility.
-
IPCA Labs Comes Under USFDA Scanner, Stock Plunges Over 15%
Earlier IPCA had discontinued manufacturing voluntarily at its Ratlam facility after USFDA had found serious issues at its Ratlam API facility.
-
Ipca Halts Shipments to US From Ratlam Plant After FDA Concerns
Ipca, a mid-sized generic drugs and ingredients maker, said the FDA issued a so-called "Form 483", a letter in which the agency typically outlines violations of its guidelines observed during inspections of manufacturing plants. Ipca did not give details about the contents of the Form 483 that it had received.
-
IPCA Lab Falls 8% on Suspension of US Shipments
The voluntarily stoppage of API shipments will impact IPCA Lab's formulations export business to the US market since its formulations units situated at Piparia (Silvassa) and SEZ, Indore (Pithampur) use APls from Ratlam for manufacturing formulations for the US market.
-
Ipca Labs Falls 15% As US Regulator Bans Drug Import
According to Ipca Laboratories, the FDA has refused admission to all drugs made at the company's Pithampur and Silvassa facility.
-
IPCA Labs Comes Under USFDA Scanner, Stock Plunges Over 15%
Earlier IPCA had discontinued manufacturing voluntarily at its Ratlam facility after USFDA had found serious issues at its Ratlam API facility.
-
Ipca Halts Shipments to US From Ratlam Plant After FDA Concerns
Ipca, a mid-sized generic drugs and ingredients maker, said the FDA issued a so-called "Form 483", a letter in which the agency typically outlines violations of its guidelines observed during inspections of manufacturing plants. Ipca did not give details about the contents of the Form 483 that it had received.
-
IPCA Lab Falls 8% on Suspension of US Shipments
The voluntarily stoppage of API shipments will impact IPCA Lab's formulations export business to the US market since its formulations units situated at Piparia (Silvassa) and SEZ, Indore (Pithampur) use APls from Ratlam for manufacturing formulations for the US market.
